WeChat Mini Program
Old Version Features

Abstract PO5-03-11: Ultra-low Dose Nivolumab Added to Dose-Dense, Cisplatin-Based Neoadjuvant Chemotherapy in Locally Advanced, Borderline Operable Triple Negative Breast Cancer: A Matched Case-Control Study

Cancer Research(2024)

Cited 0|Views10
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined